The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex

Documenti analoghi

• Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia
  di: Li, Zhimin, et al.
  Pubblicazione: (2010)
• NT79: a Novel Neurotensin Analog with Selective Behavioral Effects
  di: Boules, Mona, et al.
  Pubblicazione: (2009)
• The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia
  di: Smith, Kristin E., et al.
  Pubblicazione: (2011)
• Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance
  di: Briody, Siobhan, et al.
  Pubblicazione: (2009)
• Diverse Roles of Neurotensin Agonists in the Central Nervous System
  di: Boules, Mona, et al.
  Pubblicazione: (2013)